<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2639789/" ref="ordinalpos=630&amp;ncbi_uid=1776221&amp;link_uid=PMC2639789" image-link="/pmc/articles/PMC2639789/figure/F9/" class="imagepopup">Figure 9.  From: Role of Dickkopf-1 (Dkk1), an Antagonist of the Wnt-?-Catenin <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span>, in Estrogen-Induced Neuroprotection and Attenuation of Tau Phosphorylation. </a></div><br /><div class="p4l_captionBody">Summary diagram of E2 regulation of Wnt-β-Catenin signaling pathway following cerebral ischemia and proposed role in E2 ischemic neuroprotection. E2 acts to inhibit cerebral ischemia activation of JNK/Jun/Dkk1 signaling, which prevents subsequent phosphorylation of tau and β-Catenin and cell death, while it acts to enhances expression of Wnt3, leading to accumulation of nuclear β-Catenin and enhanced expression of survivin, which inhibits apoptosis and enhances neuronal cell survival.</div></div>